J&J said it is seeking a preliminary injunction for Samsung Bioepis' close copy of Stelara over an unauthorized sublicense ...
Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre ...
Amgen to invest $200M in new Hyderabad tech center through 2025, focusing on AI for drug development. Site opened Monday with ...
The facility, which occupies approximately 524,000 square feet across two towers in HITEC City, will focus on harnessing AI, ...
Chevron said on Monday it would reorganize some of its business structures and reshuffle the leadership team, the latest move ...
The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further ...
Hyderabad has further strengthened its position as a biotechnology and life sciences hub with the inauguration of Amgen India ...
Amgen invests $200M in India's tech center to leverage AI for drug development. The U.S. FDA seeks to rehire 300 staff ...
The employees at the new Amgen campus will reach to 600 by the end of this year and is expected to provide employment to over ...
Amgen (NASDAQ: AMGN) is investing $200 million in its new technology and innovation center in Hyderabad, India, to enhance AI ...
Amgen (AMGN) plans to invest about $200M this year in its new technology center in southern India, with further investments planned, Reuters’ ...
Amgen India opens in Hyderabad, investing $200 million in technology and innovation to advance global healthcare.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results